Related Experiment Video
Updated: Jun 4, 2025
06:37
Immunolabelling Myofiber Degeneration in Muscle Biopsies
Published on: December 5, 2019
8.7K
Jessner Lymphocytic Infiltrate in Anti-HMGCR Myopathy
Joshua Prenner1, Esther Choi1,2, Yoo Jung Kim1
1Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
JAMA Dermatology
|December 23, 2024
Abstract
No abstract available in PubMed .
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
01:15Myasthenia Gravis: Diagnostic Tests
642
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
642